Regional Treasury Center Senior Analyst
About the job
- At least 5 years of experience in treasury, corporate finance, accounting, financial planning, or related areas.
- Strong analytical ability and attention to detail.
- Ability to build effective working relationships with internal teams and financial institutions.
- Proactive, solution-oriented, and collaborative approach.
- Advanced Microsoft Excel skills.
- Proficiency with SAP S/4HANA or earlier versions.
- Professional degree in Business Administration, Finance, Accounting, Economics, or related areas.
- Intermediate to advanced English proficiency is required.
- Manage daily treasury operations, including bank reconciliations, balance monitoring, and liquidity control.
- Prepare and analyze cash positions and cash-flow forecasts to support short- and medium-term financial planning.
- Execute payments, bank transfers, and intercompany transactions, ensuring accuracy and compliance with established processes.
- Monitor and optimize cash flows and working capital by analyzing financial indicators and key metrics.
- Manage foreign-exchange exposure and follow up on currency transactions, hedges, and associated financial results.
- Manage operational relationships with banking entities, including bank accounts, financial services, and payment systems.
- Ensure compliance with corporate policies and internal controls, and maintain proper documentation of treasury processes.
- Participate in continuous-improvement projects, process automation, and initiatives that strengthen treasury efficiency and performance.
- Support corporate and strategic activities, including reorganizations, intercompany financing, insurance, and other regional financial initiatives.
- Knowledge of treasury processes, cash management, financial analysis, or financial systems.
- Knowledge of operational processes in Brazil, including tax payments, vendors, and banks.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave